Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Prostatic Neoplasms 95Breast Neoplasms 12Neoplasms 7Leiomyoma 4Rare Diseases 2Polycystic Ovary Syndrome 2Neoplasm Metastasis 2Adenocarcinoma 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunction, Physiological 1Respiratory Tract Diseases 1Prostatic Diseases 1Primary Dysautonomias 1Premenopausal Breast Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Myofibroma 1Myelodysplastic Syndromes 1Melanoma 1Lymphatic Metastasis 1Lower Urinary Tract Symptoms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1

Interventions

montanide ISA 51 2Interleukin-2 2Vincristine 1Topotecan 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Peptides 1MART-1 Antigen 1MAGEA3 protein, human 1Leuprolide 1Laparotomy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Eye Enucleation 1Etoposide 1Doxorubicin 1D-methadone 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Eye Neoplasms × Leuprolide × Clear all
NCT00254397 2019-10-16

Melanoma Vaccine With Peptides and Leuprolide

M.D. Anderson Cancer Center

Phase 2 Completed
98 enrolled 11 charts
Dermatologic

Uveal Melanoma, Eye Neoplasms, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡